Atlas Trials

Efficacy and Safety of Oral Administration of Postibiotic by FOS Fermentation From Lactobacillus Paracasei in the Treatment of Irritable Bowel Syndrome.

Clinical trial NCT06423001 · UNKNOWN

Trial details

NCT number
NCT06423001
Sponsor
Istituto Clinico Humanitas
Status
UNKNOWN
Phase
Not Applicable
Study type
INTERVENTIONAL
IBS - Irritable Bowel Syndrome
Start date
2024-06-15
Primary completion
2025-05-15
Enrollment
36

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.